Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction

Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050

The Molecular Mechanism of Amyloidosis in Alzheimer’s Disease

Zagorski, M. G. (1999) · CRC Press eBooks · doi:10.1201/9780203909607.ch14 · Cited by 1

Production of Amyloid β Protein from Normal and Mutated Amyloid β Protein Precursors

Golde, T. E., Cai, X., Cheung, T. T., Shoji, M., & Younkin, S. G. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_4 · Cited by 1

Synthesis of Alzheimer's (1–42) Aβ-amyloid peptide with preformed Fmoc-aminoacyl fluorides

Milton, S. C. F., Milton, R. C. D. L., Kates, S. A., & Glabe, C. G. (1997) · Techniques in protein chemistry · doi:10.1016/s1080-8914(97)80083-x · Cited by 1

Mechanism of Cerebral Amyloidosis in Alzheimer’s Disease

Allsop, D., Clements, A., Kennedy, H., Walsh, D. M., & Williams, C. H. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_5 · Cited by 1

γ‐Secretase Inhibition: An Overview of Development of Inhibitors for the Treatment of Alzheimer's Disease

Hamblett, C. L., Shah, S., Heidebrecht, R. W., & Muñoz, B. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527630943.ch13 · Cited by 1

Metal-amyloid-β peptide interactions: a preliminary investigation of molecular mechanisms for Alzheimer’s disease

Jiao, Y., & Yang, P. (2007) · Science China Chemistry · doi:10.1007/s11426-007-0077-x · Cited by 1

ChemInform Abstract: Low‐Cost, Fast, Convenient Peptide Synthesis with HCTU and Automated Peptide Synthesizers

Hood, C. A., Fuentes, G., Patel, H., Page, K., Menakuru, M., & Park, J. H. (2009) · ChemInform · doi:10.1002/chin.200932270

Development and Characterization of a Monoclonal Antibody 369.2B Specific for the Carboxyl‐Terminus of the βA4 Peptide

KÖNIG, G., GRAHAM, P., Bushnell, A. F., Webster, S. M., Wunderlich, D. A., & Perlmutter, L. S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34444.x · Cited by 1

Proteomic strategies for analysis of cerebrospinal fluid in neurodegenerative disorders

Hansson, S. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1

A study of b-secretase cleaved Alzheimer amyloid precursor protein

Sennvik, K. (2002) · Figshare · Cited by 1

The presenilins as potential drug targets in Alzheimer’s disease

Cupers, P., Annaert, W. G., & Strooper, B. D. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.3.413 · Cited by 3

Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance

Bharadwaj, P. (2011) · Australasian Journal of Paramedicine · Cited by 1

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, . . .

Riek, R., Güntert, P., Döbeli, H., Wipf, B., & Kurt Wüthrich, A. (2001) · Cited by 1

Entrada de calcio inducida por los oligómeros del péptido amiloide en la Enfermedad de Alzheimer

Ortega, E. C. (2013) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/3786 · Cited by 1

Structural Characterization and Membrane Interactions of the Amyloid Peptide PrP(106-126)

Walsh, P. J. (2013) · TSpace (University of Toronto) · Cited by 1

Metabolic Abnormalities in Alzheimer Disease

Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1

Chemical Synthesis of Microtubule-Associated Protein Tau 2N4RPreprint

Powell, W. C., Jing, R., & Walczak, M. A. A. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-js9bp

p53, a Molecular Bridge Between Alzheimer’s Disease Pathology and Cancers?

Checler, F., Dunys, J., Pardossi‐Piquard, R., & da Costa, C. A. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0_8

Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease

Gandy, S. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_15

Apoptosis and Alzheimer’s Disease: A Self-Assembly and the Initiation of Apoptosis by Plasma Membrane Receptor Cross-Linking

Cotman, C. W., Cribbs, D. H., & Su, J. H. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_16

Microglial involvement in brain physiopathology: in vitro studies using rat primary cultures

Mengoni, I. (2014) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6466

IN VIVO OXIDATIVE STRESS IN ALZHEIMER DISEASE BRAIN AND A MOUSE MODEL THEREOF: EFFECTS OF LIPID ASYMMETRY AND THE SINGLE METHIONINE RESIDUE OF AMYLOID-β PEPTIDE

Lange, M. B., & Lu, M. (2010)

Tianeptine induces GluA1 phosphorylation and subsequent alteration of the firing properties of CA1 neurons

Barkóczi, B. (2013) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1769

Neurobiologic Basis of Age-Related Dementing Disorders

Hof, P. R., Bussière, T., Buxbaum, J. D., & Morrison, J. H. (2006) · Springer eBooks · doi:10.1007/0-387-22621-4_76

Investigating the Role of the Amyloid Precursor Protein in the Pathogenesis of Alzheimer's Disease

Lefort, R. (2011) · doi:10.7916/d8kp884b

Mechanisms of Brain Region-Specific Amyloid-beta Deposition

Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2

Interactions between neuronal nicotinic acetylcholine receptors, N-Methyl-Aspartate receptors and beta-amyloid in the brain of genetically modified mice : Implications for Alheimer´s disease

Lithner, C. U. (2005) · Figshare

Presenilins and β-Amyloid Precursor Protein-Proteolytically Processed Proteins Involved in the Generation of Alzheimer’s Amyloid β Peptide

Haass, C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_20

Biophysical Investigations of the Aβ Aggregation Process

Muni, S. C. (2014) · D-Scholarship@Pitt (University of Pittsburgh)

Transgenic Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease

Wong, P. C., Borchelt, D., Lee, M. K., Thinakaran, G., Sisodia, S. S., & Price, D. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50008-7

Regulierung und Verfügbarkeit von Apolipoprotein E in Astrozyten

Hamker, U. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15272

Processing of the amyloid precursor protein and its paralogues amyloid precursor-like proteins 1 and 2

Adlerz, L. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

A Mini Review on Aβ Oligomers and its Pathogencity

Tuyet, P. T. D. (2014) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2014.7.2.79

Agnes Henschen-Edman, M.D., Ph.D. April 1, 1935 to October 23, 2011

Blombäck, M., & Lord, S. T. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.06.019

A Correlative Study on Amyloid-β Variants Exhibit Different Cytotoxicities Depending on Ratio of β40 to Aβ42 and Their Interaction Time and Implication of Aβ40 as a Primary Determinant for the Variable Cytotoxicities in Wild-type, Flemish and Dutch

Jayalal, L. P. M. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.1.021

The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: II Experimental Evidence and Clinical Studies

Panegyres, P. K., & Atkins, E. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.23033

SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID

Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)

New Structural View on How Amyloid Beta Production Hints Alzheimer’s Disease Pathology

Yan, X., Yang, Q., Howe, J., Fu, Q., & Wang, L. (2014) · Postdoc Journal · doi:10.14304/surya.jpr.v2n9.7

Die Molekularbiologie der Alzheimer-Krankheit

Urmoneit, B. (1999) · Springer eBooks · doi:10.1007/978-3-642-60231-3_11

Fibrillar aggregations of pathogenic pro-vasopressin mutants

Birk, J. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005148703

Targeting cytotoxic species in amyloid diseases

Persson, M. (2012)

Na,K-ATPase α Subunit-like Immunoreactive Proteins in Human Body Fluids

Peng, J. F. (2006) · American Journal of Immunology · doi:10.3844/ajisp.2006.8.11

Métabolisme du peptide

Dumanchin‐Njock, C., Lopez‐Perez, E., Marambaud, P., Paitel, E., Petit-Paitel, A., & Vincent, B. (2002)

DecreasedBrain-DerivedNeurotrophicFactorDependson AmyloidAggregationStateinTransgenicMouseModelsof Alzheimer'sDisease

Garzon, D. J., & Mount, J. (2009)

Studies on -secretase activity and products

Frånberg, J. (2010)

The inhibitory activities of constituents of the three main categorites in ginkgo biloba towards amyloidi-ß peptide aggregation

Xie, H. (2014) · HKBU Institutional Repository (Hong Kong Baptist University)

透過金屬離子結合、家族性突變型、以及奈米金粒子瞭解阿茲海默症乙型類澱粉蛋白纖維化的複雜性

廖宜鴻 (2014) · doi:10.6342/ntu.2014.00879

Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma Implications for Alzheimer's disease

Pannee, J. (2015)

The Roles of Zinc and Copper in the Function and Metabolism of the Amyloid Protein Precursor Superfamily

Bush, A. I., Pettingell, W. H., & Tanzi, R. E. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_16

Chaperone DnaK and its Influence on Multiple Steps of Formation of Amyloid beta Structural Species Results in Differential Effects on Amyloid Beta Oligomer Formation and Concomitant Cytotoxicity

Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.4.220

IMMUNOCYTOCHEMICAL STUDY OF AMYLOID β PROTEIN PRECURSOR IN MOUSE AND RAT BRAINS

Kawarabayashi, T. (1993) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.43.11

A Study on Cytotoxicities of Aβ40 to Aβ42 in Contract to Time and Concentration with the Comparison of Wild-Type and Mutants

Tuyet, P. T. D. (2014) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2014.7.1.11

Evaluating the Potential Therapeutic Role of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Alzheimer's Disease using a Drosophila Model

Gomes, S. M. (2017) · TSpace (University of Toronto)

The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease

Chopra, N. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c28019

Alpha-synuclein expression influences the processing of the amyloid precursor protein

Hall‐Roberts, H. (2016) · The University of Bath Online Publications Store (The University of Bath)

Cognitive and Non-Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease

Lee, W.-J. (2017) · Scholarship@Western (Western University)

Bioanalytical approach to the interaction of novel sym-triazine derivatives with Alzheimer's disease biomarkers

Liu, A. W. K. (2015) · TSpace (University of Toronto)

Polymorphism of Alzheimer’s Aβ Amyloid Fibrils and Oligomers

Antzutkin, O. N. (2018) · Springer eBooks · doi:10.1007/978-3-319-28388-3_31

Mechanisms of Memory Deficits in Mouse Models of Alzheimer's Disease

Yiu, A. P. (2012) · TSpace (University of Toronto)

Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer

Bartlau, T. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5745

Remodelado del calcio intracelular y susceptibilidad a la muerte neuronal en el envejecimiento y en la enfermedad de Alzheimer

Rodríguez, M. C. (2015) · doi:10.35376/10324/16193

The toxicity of protein aggregates in several neurodegenerative diseases

Alimi, I. (2018)

Amyloid aggregates: detection and interaction

Rahman, M. M. (2018) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))

THE CONTRIBUTION OF MOSAIC MUTATION TO AUTISM SPECTRUM DISORDER

Freed, D. N. (2017)

Direct Visualization of Single Molecule Amyloid Beta Peptides in Action by High-Speed Atomic Force Microscopy

Feng, L. (2019) · Research Online (University of Wollongong)

Alzheimer's Disease

JAMISON, J. (2003) · Elsevier eBooks · doi:10.1016/b978-0-443-07193-5.50014-5

Key Nucleation Stages and Associated Molecular Determinants and Processes in pH-Induced Formation of Amyloid Beta Oligomers as Revealed by High-Speed AFMPreprint

Feng, L., Watanabe, H., Molino, P. J., Wallace, G. G., Phung, S. L., Uchihashi, T., & Higgins, M. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.17.343830

Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature

Noor, A. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7997

βAPP Metabolites, Radicals, Calcium, and Neurodegeneration: Novel Neuroprotective Strategies

Mattson, M. P., Barger, S. W., Furukawa, K., Mark, R. J., Smith‐Swintosky, V. L., Pettigrew, L. C., & Bruce‐Keller, A. J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_38

Characterisation of the ghrelinergic system in human models of neurodegenerative diseases

Carisi, M. C. (2021) · Cronfa (Swansea University) · doi:10.23889/suthesis.58915

Alzheimer’s Disease

Siman, R., & Greenberg, B. (1996) · Humana Press eBooks · doi:10.1007/978-1-59259-466-5_10

Improved synthesis and purification of Alzheimer's Aβ 1–42 and analogs

Milton, S. C. F., Milton, R. C. D. L., Kates, S. A., & Glabe, C. G. (1999) · Letters in Peptide Science · doi:10.1023/a:1008858416745

Nicht-VSEPR-Strukturen und chemische Bindung in d0-Systemen

Kaupp, M. (2001) · Angewandte Chemie · doi:10.1002/1521-3757(20011001)113:19 · Cited by 50

Processing of Alzheimer Aβ-Amyloid Precursor Protein: Cell Biology, Regulation, and Role in Alzheimer’s Disease

Gandy, S., & Greengard, P. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_10

Einfluss von prä-analytischen Entnahme- und Lagerungsbedingungen auf die Stabilität und Konzentration von Amyloid-ß-Peptiden in Blut

Walter, M. (2022) · doi:10.53846/goediss-9330

Targeting Various Pathogenic Pathways for the Development of Anti-alzheimer’s Drugs: An Update

Ambreen, S., Fatima, N., Umar, M., Shaququzzaman, M., Alam, M. M., & Ali, R. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266274924231002110733

Laboratory Findings of NPH

Bubeníková, A., Máčová, L., Skalický, P., Mládek, A., & Bradáč, O. (2023) · Springer eBooks · doi:10.1007/978-3-031-36522-5_15

The nature of tyrosine-aminated amyloid-βPreprint

Gao, Z., Hu, T., Wu, J., Fu, S., & Li, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3752850/v1

Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region

Paterno, G., Moore, B. D., Bell, B. M., Gorion, K.-M. M., Ran, Y., Prokop, S., Golde, T. E., & Giasson, B. I. (2024) · Antibodies · doi:10.3390/antib13030068

Microglial glutathione and glutamate: regulation mechanisms

Fry, V. A. H. (2009) · UCL Discovery (University College London)

Aß Toxicity in Alzheimer’s Disease

Klein, W. L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_1 · Cited by 14

Mechanistic insights into amyloid β fibril disruption by ginsenosides through molecular dynamics simulations

Ahmed, S., Barale, S. S., Kamble, R. S., Fatema, K., Sonawane, K. D., Hefferon, K. L., Paek, K., & Shohael, A. M. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00729-5

Collagène auto-assemblé en support 3D biomimétique fonctionnalisé pour la différenciation de cellules nerveuses

Labour, M.-N. (2012) · doi:10.70675/6afca839za213z4543z9342z239dd2fbdfdd

Intégrité de la barrière hémato-encéphalique et transport du peptide bêta-amyloïde dans la maladie d'Alzheimer

Do, T. M. (2012) · theses.fr (ABES) · doi:10.70675/39078922z7524z4044z80dcz166165217d2b

Validation préclinique de l'efficacité de l'ANAVEX2-73 dans des modèles transgénique et non transgénique de la maladie d'Alzheimer

Lahmy, V. (2014) · theses.fr (ABES) · doi:10.70675/23744d67zb26bz4a32zadbfz3931ecca70f5

Métalloprotéases matricielles et maladie d'Alzheimer : étude du rôle de MT1-MMP dans le métabolisme de l'APP/Aß

Py, N. A. (2014) · theses.fr (ABES) · doi:10.70675/76e6e222zc088z470cza0c6za5a23187870c

Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer

Hamm, V. (2016) · theses.fr (ABES) · doi:10.70675/39443da7z44bfz4b29zbbbezb2b0dfba178a

Effets des acides gras ω-3 sur l'inflammation cérébro-vasculaire associée à la maladie d'Alzheimer et aux angiopathies amyloïdes cérébrales

Hur, J. (2017) · theses.fr (ABES) · doi:10.70675/74388921za6fcz4e1ez8033z6d776311f983

La protéine prion cellulaire : un relai de neurotoxicité commun aux protéines amyloïdes et aux nanoparticules

Boudet-Devaud, F. (2018) · theses.fr (ABES) · doi:10.70675/111341b9z5eeez4531z8f07zcb44d6f469a0

Matériaux fonctionnels par assemblage de microsphères composites de chitosane/collagène pour l’ingénierie tissulaire

Azria, D. (2018) · theses.fr (ABES) · doi:10.70675/374eb0e2z1780z45c6zb0bcz78e411668d09

Métalloprotéases matricielles et maladie d'Alzheimer : étude des rôles de MT1- et MT5-MMP dans l'amyloïdogenèse et la neuro-inflammation

Paumier, J. (2018) · theses.fr (ABES) · doi:10.70675/db80d130z8878z4515z87e4z4b26a4b02d92

Effets de l’administration de tétrahydrobioptérine en condition physiologique et pathologique : De la neurobiologie au comportement

Fanet, H. (2018) · theses.fr (ABES) · doi:10.70675/b46d2065zecc9z4e97zae20zf9e2e4fe0c69

De la fonction physiologique de la protéine prion cellulaire aux maladies neurodégénératives amyloïdes

Arnould, H. (2019) · theses.fr (ABES) · doi:10.70675/9f070729z72aez4fccz9604z8c52be1a62e6

Stade prodromal de la maladie d'Alzheimer : nature des déficits mnésiques et liens avec les biomarqueurs d'imagerie.

Tomadesso, C. (2018) · theses.fr (ABES) · doi:10.70675/7fad6418zff81z49c7z984dz63aa2e44d7fc

Altérations des synapses et des corps cellulaires neuronaux chez les souris APPxPS1-KI et dans la Maladie d'Alzheimer

Androuin, A. (2018) · theses.fr (ABES) · doi:10.70675/a4392b1fz1293z4debzbe98ze28194a21801

La protéine prion cellulaire : rôles physiologiques et implications croisées dans les maladies neurodégénératives amyloïdes

Baudouin, V. (2020) · theses.fr (ABES) · doi:10.70675/a212ad92z3b22z4eeczb177z417025bff4ef

Modulation of Alzheimer's disease amyloid beta peptide aggregation by molecular chaperones, polyphosphates and metal ions, and their interplay

Ayala, S. (2018) · theses.fr (ABES) · doi:10.70675/8da8f753z4f85z412bz9605z6ff8e95468ad

MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model

Piłat, D. (2021) · theses.fr (ABES) · doi:10.70675/0050afedz3f0bz461fzafefz4b4742f76a57

Vers une meilleure compréhension des facteurs psychoaffectifs (anxiété et dépression) dans le vieillissement normal et pathologique : liens avec la cognition et la neuroimagerie multimodale

Moulinet, I. (2020) · theses.fr (ABES) · doi:10.70675/45bad93dz6eeez45d1z8d85z5e83196b607c

Untitled work

Salin (1998) · doi:10.1002/(sici)1096-9861(19980720)397:1

Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

Hilbich, C., Kisters–Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. T. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580

Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.

Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16256.x · Cited by 82

Amyloid βA4 of Alzheimer’s Disease: Structural Requirements for Folding and Aggregation

Hilbich, C., Kisters–Woike, B., Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_3 · Cited by 2

Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease

Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 644

Structural Determinants of the Alzheimer's Amyloid β‐Peptide

Soto, C. A., Brañes, M. C., Alvarez, J., & Inestrosa, N. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041191.x · Cited by 153